Journal article · 2018 · Open access

Quality of informed consent in cancer clinical trials in India: A cross-sectional survey

Vikram S. Gota, Manjunath Nookala, Akanksha Yadav, SoniaRebecca Menezes, Sadhana Kannan, Raghib Ali

The National Medical Journal of India, 31(6), 334 · Published 1 November 2018 · DOI 10.4103/0970-258x.262900

Open full textCite this paper

In brief

“Quality of informed consent in cancer clinical trials in India: A cross-sectional survey” is a 2018 journal article by Vikram S. Gota and 5 co-authors, published in The National Medical Journal of India. OpenAlex counts 23 citations as of 22 November 2026. It is open access under a CC BY-NC-SA licence: the full text is free to read at The National Medical Journal of India.

Citations
23
Most cited in
2024 (7)
Field-weighted impact
0.60
References
23
Authors
6

Abstract

Background: An 'informed consent' is a legal and ethical requirement for research involving human subjects. Studies assessing the validity of informed consent and determinants of its quality have highlighted problems in consent delivery and comprehension by trial participants. We report the findings of a questionnaire-based survey conducted to understand the quality of informed consent (QuIC) in cancer clinical trials. Methods: The survey was conducted in a single tertiary care cancer centre in India. Patients enrolled in phase 1, 2 or 3 interventional studies were administered the QuIC questionnaire by a trained study coordinator. The QuIC, expressed as knowledge score, was calculated from the proportion of correct responses expressed as a percentage. Results: The mean (SD) knowledge score was 60.46% (1 5.21%). It was considerably higher in industry-sponsored trials compared to investigator-initiated trials (65.32% v. 52.21%, respectively; p<0.001). Faith in the treating oncologist positively influenced the patients' decision to participate in a trial. Nearly 97% of the respondents anticipated better care, while 85% felt that the new drug/procedure would be better than the existing treatment. Free treatment emerged as a strong inducement for patients to take part in clinical trials. Patients were aware of their autonomy, and responses showed that none of the patients were coerced or unduly influenced to participate in clinical trials. Conclusion: Our study revealed important deficiencies in research participants' understanding of essential elements of informed consent. Thorough patient counselling is crucial to minimize 'therapeutic misconception' to preserve the validity of informed consent in cancer trials.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Gota, V. S., Nookala, M., Yadav, A., Menezes, S., Kannan, S., & Ali, R. (2018). Quality of informed consent in cancer clinical trials in India: A cross-sectional survey. The National Medical Journal of India, 31(6), 334. https://doi.org/10.4103/0970-258x.262900

MLA 9

Gota, Vikram S., et al. “Quality of informed consent in cancer clinical trials in India: A cross-sectional survey.” The National Medical Journal of India, vol. 31, no. 6, 2018, p. 334. https://doi.org/10.4103/0970-258x.262900.

Chicago

Gota, Vikram S., Manjunath Nookala, Akanksha Yadav, SoniaRebecca Menezes, Sadhana Kannan, and Raghib Ali. 2018. “Quality of informed consent in cancer clinical trials in India: A cross-sectional survey.” The National Medical Journal of India 31 (6): 334. https://doi.org/10.4103/0970-258x.262900.

Harvard

Gota, V. S. et al. (2018) ‘Quality of informed consent in cancer clinical trials in India: A cross-sectional survey’, The National Medical Journal of India, 31(6), p. 334. doi:10.4103/0970-258x.262900.

IEEE

V. S. Gota, M. Nookala, A. Yadav, S. Menezes, S. Kannan, and R. Ali, “Quality of informed consent in cancer clinical trials in India: A cross-sectional survey,” The National Medical Journal of India, vol. 31, no. 6, p. 334, 2018, doi: 10.4103/0970-258x.262900.

BibTeX

@article{gota2018quality,
  title     = {{Quality of informed consent in cancer clinical trials in India: A cross-sectional survey}},
  author    = {Gota, Vikram S. and Nookala, Manjunath and Yadav, Akanksha and Menezes, SoniaRebecca and Kannan, Sadhana and Ali, Raghib},
  journal   = {The National Medical Journal of India},
  year      = {2018},
  volume    = {31},
  number    = {6},
  pages     = {334},
  doi       = {10.4103/0970-258x.262900},
  url       = {https://doi.org/10.4103/0970-258x.262900}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201711
202011
202122
202233
202333
202477
202522
202644

Its field-weighted citation impact is 0.60: it has been cited 0.60 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research

  • informed consent
  • cancer clinical trials
  • patient understanding
  • therapeutic misconception
  • industry-sponsored trials
  • investigator-initiated trials
  • patient autonomy
  • patient counseling

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Gota, V. S., Nookala, M., Yadav, A., Menezes, S., Kannan, S., & Ali, R. (2018). Quality of informed consent in cancer clinical trials in India: A cross-sectional survey. The National Medical Journal of India, 31(6), 334. https://doi.org/10.4103/0970-258x.262900

How many times has this paper been cited?

23 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at The National Medical Journal of India: sign in and open the full text from this page.

Who wrote this paper?

Vikram S. Gota, Manjunath Nookala, Akanksha Yadav, SoniaRebecca Menezes, Sadhana Kannan, Raghib Ali.

What is the DOI of this paper?

10.4103/0970-258x.262900, permanently at https://doi.org/10.4103/0970-258x.262900. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.